Trexquant Investment’s Aligos Therapeutics ALGS Stock Holding History

Trexquant Investment’s Portfolio ALGS Stock Details ALGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-38,254	Closed	-$316K	–	1496
2025 Q1	$316K	Sell	38,254 -30,796	-45%	-$675K	﹤0.01%	1378
2024 Q4	$2.75M	Buy	+69,050	New	+$1.33M	0.03%	748

Other funds holding ALGS

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Readystate Asset Management Chicago, Illinois $1.71B AUM 15% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return